Compile Data Set for Download or QSAR
Report error Found 81 Enz. Inhib. hit(s) with all data for entry = 1156
TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311138(example 6.09 on page 559 of WO15017610)
Affinity DataIC50: 0.100nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311136(example 5.20 on page 506 of WO15017610)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311139(example 3B.22 on page 219 of WO15017610)
Affinity DataIC50: 0.800nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311126(US10155751, Example 13)
Affinity DataIC50: 0.900nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311114(US10155751, Example 1)
Affinity DataIC50: 1nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311122(US10155751, Example 9)
Affinity DataIC50: 1.10nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311131(US10155751, Example 18)
Affinity DataIC50: 1.10nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311135(US10155751, Example 22)
Affinity DataIC50: 1.20nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311134(US10155751, Example 21)
Affinity DataIC50: 1.20nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311115(US10155751, Example 2)
Affinity DataIC50: 1.30nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311120(US10155751, Example 7)
Affinity DataIC50: 1.30nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311121(US10155751, Example 8)
Affinity DataIC50: 1.40nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311124(US10155751, Example 11)
Affinity DataIC50: 1.5nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311132(US10155751, Example 19)
Affinity DataIC50: 1.80nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311137(example 3A.02, on page 196 of WO15017610)
Affinity DataIC50: 1.90nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311116(US10155751, Example 3)
Affinity DataIC50: 2nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311128(US10155751, Example 15)
Affinity DataIC50: 2.20nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311117(US10155751, Example 4)
Affinity DataIC50: 2.20nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311133(US10155751, Example 20)
Affinity DataIC50: 2.5nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311119(US10155751, Example 6)
Affinity DataIC50: 2.60nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311130(US10155751, Example 17)
Affinity DataIC50: 2.90nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311125(US10155751, Example 12)
Affinity DataIC50: 2.90nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311129(US10155751, Example 16)
Affinity DataIC50: 3.10nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311127(US10155751, Example 14)
Affinity DataIC50: 3.20nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311118(US10155751, Example 5)
Affinity DataIC50: 3.30nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311123(US10155751, Example 10)
Affinity DataIC50: 3.30nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311140(example 6.60 on page 587 of WO15017610)
Affinity DataIC50: 10.3nMAssay Description:Recombinant human SYK (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag. The test compounds were dissolved in 100% D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311138(example 6.09 on page 559 of WO15017610)
Affinity DataIC50: 25nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetAurora kinase B [1-341](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311138(example 6.09 on page 559 of WO15017610)
Affinity DataIC50: 37nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311136(example 5.20 on page 506 of WO15017610)
Affinity DataIC50: 43nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetAurora kinase B [1-341](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311136(example 5.20 on page 506 of WO15017610)
Affinity DataIC50: 162nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311139(example 3B.22 on page 219 of WO15017610)
Affinity DataIC50: 307nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311137(example 3A.02, on page 196 of WO15017610)
Affinity DataIC50: 384nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetAurora kinase B [1-341](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311139(example 3B.22 on page 219 of WO15017610)
Affinity DataIC50: 771nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311116(US10155751, Example 3)
Affinity DataIC50: 1.34E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetAurora kinase B [1-341](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311137(example 3A.02, on page 196 of WO15017610)
Affinity DataIC50: 1.69E+3nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311122(US10155751, Example 9)
Affinity DataIC50: 1.84E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311135(US10155751, Example 22)
Affinity DataIC50: 1.95E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311123(US10155751, Example 10)
Affinity DataIC50: 2.02E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311121(US10155751, Example 8)
Affinity DataIC50: 2.07E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311134(US10155751, Example 21)
Affinity DataIC50: 2.21E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311114(US10155751, Example 1)
Affinity DataIC50: 2.23E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311120(US10155751, Example 7)
Affinity DataIC50: 2.44E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311115(US10155751, Example 2)
Affinity DataIC50: 2.83E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311133(US10155751, Example 20)
Affinity DataIC50: 3.32E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311124(US10155751, Example 11)
Affinity DataIC50: 3.48E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311129(US10155751, Example 16)
Affinity DataIC50: 3.49E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311119(US10155751, Example 6)
Affinity DataIC50: 3.73E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311118(US10155751, Example 5)
Affinity DataIC50: 3.99E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [564-960](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM311127(US10155751, Example 14)
Affinity DataIC50: 4.05E+3nMAssay Description:Recombinant human FLT3 (amino acids 564-958, Molecular weight 48.6 kDa, Invitrogen #PR4666C) was expressed with an Histidine tag. The test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 81 total ) | Next | Last >>
Jump to: